Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Barrett's oesophagus.

R M Navaratnam1, M C Winslet

  • 1University Department of Surgery, Royal Free Hospital, London, UK.

Postgraduate Medical Journal
|April 10, 1999
PubMed
Summary
This summary is machine-generated.

Barrett's oesophagus, a pre-malignant condition caused by acid reflux, increases cancer risk. Management includes proton pump inhibitors, with surgery for severe cases and surveillance for dysplasia.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Systematic review on the treatment of ischaemic colitis.

Colorectal disease : the official journal of the Association of Coloproctology of Great Britain and Ireland·2010
Same author

The influence of symptom type and duration on the fate of the metaplastic columnar-lined Barrett's oesophagus.

Alimentary pharmacology & therapeutics·2009
Same author

Increased apoptosis and decreased proliferation of colorectal cancer cells using insulin-like growth factor binding protein-4 gene delivered locally by gene transfer.

Colorectal disease : the official journal of the Association of Coloproctology of Great Britain and Ireland·2007
Same author

Impact of HIV and AIDS on surgical practice.

Annals of the Royal College of Surgeons of England·2007
Same author

A review of the epidemiology, pathogenesis and management of tetanus.

International journal of surgery (London, England)·2007
Same author

EpCAM an immunotherapeutic target for gastrointestinal malignancy: current experience and future challenges.

British journal of cancer·2007
Same journal

Dapagliflozin-induced anaphylactic shock.

Postgraduate medical journal·2026
Same journal

Comparative efficacy of Janus kinase inhibitors in severe alopecia areata: a network meta-analysis based on randomized controlled trials.

Postgraduate medical journal·2026
Same journal

Two cases of toxic epidermal necrolysis with severe ocular involvement treated with adjunctive tofacitinib.

Postgraduate medical journal·2026
Same journal

Diastolic dysfunction and diabetes: the DIADAD study-a retrospective cohort study from Liverpool.

Postgraduate medical journal·2026
Same journal

Care, cash, and proof: forensic accountability for war-related starvation.

Postgraduate medical journal·2026
Same journal

Response to traumatic injuries in polo players in England.

Postgraduate medical journal·2026
See all related articles

Area of Science:

  • Gastroenterology
  • Oncology
  • Gastroesophageal Reflux Disease

Background:

  • Barrett's oesophagus involves squamous to columnar epithelial change in the distal oesophagus.
  • Gastro-oesophageal reflux is the primary cause, affecting 40% of adults.
  • It is a pre-malignant condition with a 25-130 fold increased risk of malignancy.

Purpose of the Study:

  • To review the etiology, diagnosis, and management of Barrett's oesophagus.
  • To highlight the association between Barrett's oesophagus and increased risk of esophageal adenocarcinoma.
  • To discuss current treatment strategies and the need for lifelong surveillance.

Main Methods:

  • Review of existing literature on Barrett's oesophagus and gastro-oesophageal reflux.
  • Analysis of reported incidence rates and complication prevalence.

Related Experiment Videos

  • Evaluation of treatment outcomes for medical and surgical interventions.

    • Main Results:

    • Barrett's oesophagus affects 11-18% of symptomatic reflux patients, with 50% presenting with complications like cancer.
    • Reduced oesophageal sensitivity to acid contributes to symptom disparity.
    • Photodynamic therapy shows promise for high-grade dysplasia, but lifelong surveillance is essential.

    Conclusions:

    • Barrett's oesophagus is a significant risk factor for esophageal adenocarcinoma.
    • Proton pump inhibitors are first-line treatment for symptomatic cases.
    • Surgery is reserved for specific cases, and surveillance is crucial due to potential recurrence.